ArticleScandinavian journal of immunology2026
Impact of Bacterial Membrane Vesicles on Cellular Responses in Leishmania amazonensis-Infected Macrophages In Vitro.
Article in Scandinavian journal of immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Leishmania amazonensis is an intracellular protozoan parasite and etiological agent of Localised Cutaneous Leishmaniasis (LCL). A challenge in managing LCL is the frequent occurrence of secondary bacterial co-infections caused by opportunistic bacteria such as Pseudomonas aeruginosa and Staphylococcus aureus. This study aimed to evaluate the effects of Bacterial Membrane Vesicles (BMVs) from these bacteria on macrophages infected with L. amazonensis. BMVs were characterised by Nanoparticle Tracking Analysis (NTA), and their effects on macrophage viability, infection dynamics, and cytokine production were assessed. Macrophages infected with L. amazonensis and subsequently treated with BMVs exhibited reduced parasite burden and cell viability compared to infected controls. The production of cytokines was variably modulated depending on the vesicle source. TNF-α levels were higher in macrophages infected with L. amazonensis and treated with BMVs than in those infected with the parasite alone. Additionally, elevated levels of IL-1β were observed in co-cultures treated with P. aeruginosa membrane vesicles (POMVs), suggesting a stronger inflammatory profile than that induced by S. aureus extracellular vesicles (SEVs). In contrast, IL-4 and IL-6 levels were not significantly affected by either POMVs or SEVs. These results indicate that uninfected and L. amazonensis-infected macrophages respond distinctly to POMVs and SEVs, particularly through enhanced secretion of IL-1β and TNF-α. In conclusion, macrophages exposed to both L. amazonensis and bacterial vesicles simulate a host-parasite-bacteria interaction, activating production of cytokines. Given their immunogenic properties, BMVs may represent promising targets for the development of therapeutic strategies associated with LCL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.